Salvage Chemoradiotherapy for Locally Recurrent Bile Duct Cancer

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter J.I. Yu
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors J.I. Yu1, H.C. Park1, D.H. Lim1, S.T. Kim1, Y.S. Park1, J.O. Park2, S.H. Choi1, D.W. Choi1, J.S. Heo1
  • 1Samsung Medical Center, Seoul, Republic of Korea, /
  • 2Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, /

Abstract

We investigated the clinical outcome and prognostic factors of chemoradiotherapy (CRT) for locally recurrent bile duct cancer after curative surgical resection.